A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: fate (4), casualty (43), fatal accident (4), death (217)

Cabazitaxel-Prednisolone

Description
Chemotherapy Protocol PROSTATE CABAZITAXEL-PREDNISOLONE Regimen • Prostate-Cabazitaxel-Prednisolone Indication • Castrate resistant metastatic prostate
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Cabazitaxel-Prednisolone.pdf

UHS adult major trauma guidelines

Description
Adult Major Trauma Guidelines University Hospital Southampton NHS Foundation Trust Dr Mark Baxter Director of Major Trauma, Consultant in Older Persons
Url
/Media/SUHTExtranet/WessexTraumaNetwork/UHS-adult-major-trauma-guidelines.pdf

Vitamin K supplements for newborn babies - patient information

Description
This factsheet explains what vitamin K is, why it is recommended for newborn babies and what your options are when your
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Vitamin-K-supplements-for-newborn-babies-2143-PIL.pdf

Enhertu (trastuzumab deruxtecan)

Description
Chemotherapy Protocol BREAST CANCER ENHERTU (trastuzumab deruxtecan) ENHERTU is NOT the same drug as Kadcyla (trastuzumab emtansine) or generic trastuzumab). There
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Enhertu-trastuzumab-deruxtecan.pdf

Papers Trust Board - 15 July 2025

Description
Agenda Trust Board – Open Session Date 15/07/2025 Time 9:00 - 13:00 Location Conference Room, Heartbeat Education Centre
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-15-July-2025.pdf

Papers Trust Board 6 June 2024

Description
Date Time Location Chair Apologies Agenda Trust Board – Open Session 06/06/2024 9:00 - 13:00 Conference Room, Heartbeat/Mic
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-6-June-2024.pdf

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory/relapsed euroblastoma Version 8.0 dated 07-Mar-2023 Dinutuximab beta amendment Coordinating Sponsor: Sponsor Protocol Number: CAS Code: EudraCT Number: ISRCTN Reference Number: ITCC Number: Roche Study Reference Number: Email: University of Birmingham RG_ 11-087 BN2008 2012-000072-42 40708286 032 MO28245 beaco
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf
1 to 7 of 7